NanoGuardian to partner with SDI's Closed-Loop Protection market monitoring program

SKOKIE, Ill. A company that markets brand protection technology to prevent diversion of prescription drugs will partner with a company that provides analytics for the pharmaceutical and healthcare industries.

NanoGuardian announced Tuesday its partnership with SDI to deliver its Closed-Loop Protection market monitoring program, saying it would combine NanoGuardian’s on-dose authentication and tracing technology with SDI’s pharmacy auditing program to identify counterfeit and diverted pharmaceuticals entering the supply chain.

The Center for Medicines in the Public Interest estimates that commerce in counterfeit drugs will increase by 13% a year through 2010, generating $75 billion in revenues.